STAGE IIIB PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIIB PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tested a new drug (AZD8186) combined with chemotherapy (docetaxel) in 23 people with advanced solid tumors that have certain gene mutations (PTEN or PIK3CB). The main goals were to find the best dose and check for side effects. The study was completed, but …
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
New radiation schedule shows promise for High-Risk prostate cancer
Disease control CompletedThis study tested a shorter course of radiation (hypofractionation) in 52 men with prostate cancer who had high-risk features after their prostate was removed. The goal was to see if giving higher doses over fewer sessions could better control the cancer and reduce side effects. …
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New drug combo shows promise in keeping High-Risk prostate cancer at bay
Disease control CompletedThis study looked at whether adding a drug called niraparib to the usual treatment (radiation plus hormone therapy) can help prevent high-risk prostate cancer from growing or coming back. Niraparib works by blocking a repair process that cancer cells rely on, causing them to die.…
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Cancer moonshot study banks tissue to unlock genetic secrets
Knowledge-focused CompletedThis study collected blood and tumor tissue from 64 people with advanced or treatment-resistant cancers. Researchers stored these samples to study how genes affect cancer growth and response to therapy. The goal is to better understand why some cancers stop responding to treatmen…
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 03:26 UTC
-
Smart devices track cancer recovery at home
Knowledge-focused CompletedThis study looked at whether using at-home monitoring devices (like a wristband pedometer, scale, and blood pressure cuff) can help improve care for cancer patients after they leave the hospital following surgery. 22 people with different cancers took part. The goal was to see if…
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
New app helps prostate cancer patients decide on genetic testing
Knowledge-focused CompletedThis study tested a mobile-friendly tool that helps men with prostate cancer learn about genetic testing and decide if they want it. The tool includes educational modules and a way to collect family history. The goal was to see if the tool works well and helps patients make infor…
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC